annual SGA:
$0.00-$12.52B(-100.00%)Summary
- As of today (August 19, 2025), NVS annual SGA is $0.00, with the most recent change of -$12.52 billion (-100.00%) on December 31, 2024.
- During the last 3 years, NVS annual SGA has fallen by -$14.89 billion (-100.00%).
- NVS annual SGA is now -100.00% below its all-time high of $17.86 billion, reached on December 31, 2011.
Performance
NVS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$3.50B+$439.27M(+14.36%)Summary
- As of today (August 19, 2025), NVS quarterly SGA is $3.50 billion, with the most recent change of +$439.27 million (+14.36%) on June 30, 2025.
- Over the past year, NVS quarterly SGA has increased by +$406.27 million (+13.14%).
- NVS quarterly SGA is now -31.15% below its all-time high of $5.08 billion, reached on December 31, 2010.
Performance
NVS quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$174.22B-$4.31B(-2.41%)Summary
- As of today (August 19, 2025), NVS TTM SGA is $174.22 billion, with the most recent change of -$4.31 billion (-2.41%) on June 30, 2025.
- Over the past year, NVS TTM SGA has increased by +$161.75 billion (+1297.55%).
- NVS TTM SGA is now -19.95% below its all-time high of $217.64 billion.
Performance
NVS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NVS Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | +13.1% | +1297.5% |
3 y3 years | -100.0% | -2.3% | +1085.5% |
5 y5 years | -100.0% | +3.8% | +1117.6% |
NVS Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.0% | at low | -2.3% | >+9999.0% | -19.9% | +174.2% |
5 y | 5-year | -100.0% | at low | -12.2% | >+9999.0% | -19.9% | +204.8% |
alltime | all time | -100.0% | at low | -31.1% | >+9999.0% | -19.9% | +630.2% |
NVS Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $3.50B(+14.4%) | $9.69B(+4.4%) |
Mar 2025 | - | $3.06B(>+9900.0%) | $9.28B(+2.4%) |
Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $9.06B(-27.5%) |
Sep 2024 | - | $3.13B(+1.4%) | $12.51B(+0.3%) |
Jun 2024 | - | $3.09B(+8.8%) | $12.47B(0.0%) |
Mar 2024 | - | $2.84B(-17.5%) | $12.47B(-0.4%) |
Dec 2023 | $12.52B(+2.7%) | $3.44B(+11.4%) | $12.52B(+2.1%) |
Sep 2023 | - | $3.09B(0.0%) | $12.26B(+1.3%) |
Jun 2023 | - | $3.09B(+6.9%) | $12.10B(-3.9%) |
Mar 2023 | - | $2.89B(-9.2%) | $12.59B(-4.7%) |
Dec 2022 | $12.19B(-18.1%) | $3.18B(+8.4%) | $13.21B(-5.7%) |
Sep 2022 | - | $2.94B(-18.0%) | $14.01B(-4.6%) |
Jun 2022 | - | $3.58B(+2.0%) | $14.70B(-1.2%) |
Mar 2022 | - | $3.51B(-11.9%) | $14.87B(-0.1%) |
Dec 2021 | $14.89B(+4.9%) | $3.98B(+10.1%) | $14.89B(+0.4%) |
Sep 2021 | - | $3.62B(-3.6%) | $14.82B(+1.4%) |
Jun 2021 | - | $3.75B(+6.4%) | $14.63B(+2.7%) |
Mar 2021 | - | $3.53B(-10.1%) | $14.24B(+0.3%) |
Dec 2020 | $14.20B(-1.2%) | $3.92B(+14.8%) | $14.20B(+0.1%) |
Sep 2020 | - | $3.42B(+1.5%) | $14.18B(-0.9%) |
Jun 2020 | - | $3.37B(-3.4%) | $14.31B(-1.5%) |
Mar 2020 | - | $3.49B(-10.7%) | $14.53B(+1.1%) |
Dec 2019 | $14.37B(+4.8%) | $3.90B(+10.0%) | $14.37B(+1.6%) |
Sep 2019 | - | $3.55B(-1.0%) | $14.14B(+2.1%) |
Jun 2019 | - | $3.58B(+7.7%) | $13.85B(+0.7%) |
Mar 2019 | - | $3.33B(-9.4%) | $13.76B(+0.3%) |
Dec 2018 | $13.72B(-8.5%) | $3.68B(+12.8%) | $13.72B(-2.6%) |
Sep 2018 | - | $3.26B(-6.7%) | $14.08B(-2.9%) |
Jun 2018 | - | $3.50B(+6.4%) | $14.50B(-2.1%) |
Mar 2018 | - | $3.28B(-18.7%) | $14.81B(-1.3%) |
Dec 2017 | $15.00B(+5.7%) | $4.04B(+9.9%) | $15.00B(+1.4%) |
Sep 2017 | - | $3.68B(-3.4%) | $14.79B(+1.9%) |
Jun 2017 | - | $3.81B(+9.6%) | $14.52B(+1.1%) |
Mar 2017 | - | $3.47B(-9.5%) | $14.36B(+1.2%) |
Dec 2016 | $14.19B(-0.4%) | $3.84B(+12.9%) | $14.19B(-0.3%) |
Sep 2016 | - | $3.40B(-6.8%) | $14.24B(-0.4%) |
Jun 2016 | - | $3.65B(+10.4%) | $14.30B(+0.2%) |
Mar 2016 | - | $3.31B(-14.9%) | $14.27B(+0.2%) |
Dec 2015 | $14.25B(-5.0%) | $3.88B(+12.2%) | $14.25B(-0.6%) |
Sep 2015 | - | $3.46B(-4.3%) | $14.33B(-0.7%) |
Jun 2015 | - | $3.62B(+10.2%) | $14.43B(-1.9%) |
Mar 2015 | - | $3.28B(-17.2%) | $14.71B(-6.7%) |
Dec 2014 | $14.99B(-1.6%) | $3.96B(+11.2%) | $15.76B(-1.1%) |
Sep 2014 | - | $3.56B(-8.6%) | $15.94B(-0.7%) |
Jun 2014 | - | $3.90B(-10.0%) | $16.05B(+0.7%) |
Mar 2014 | - | $4.33B(+4.5%) | $15.93B(+0.6%) |
Dec 2013 | $15.24B(-11.9%) | $4.15B(+12.8%) | $15.84B(-3.0%) |
Sep 2013 | - | $3.67B(-2.9%) | $16.34B(-1.6%) |
Jun 2013 | - | $3.78B(-10.7%) | $16.60B(-2.2%) |
Mar 2013 | - | $4.24B(-8.6%) | $16.96B(+1.5%) |
Dec 2012 | $17.29B | $4.64B(+17.9%) | $16.72B(+0.1%) |
Sep 2012 | - | $3.93B(-5.2%) | $16.70B(-4.6%) |
Jun 2012 | - | $4.15B(+3.9%) | $17.51B(-4.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $3.99B(-13.5%) | $18.36B(-2.6%) |
Dec 2011 | $17.86B(+14.0%) | $4.62B(-2.6%) | $18.84B(-2.4%) |
Sep 2011 | - | $4.74B(-5.2%) | $19.30B(+5.1%) |
Jun 2011 | - | $5.00B(+11.8%) | $18.36B(+8.8%) |
Mar 2011 | - | $4.48B(-11.9%) | $16.88B(+5.6%) |
Dec 2010 | $15.67B(+9.8%) | $5.08B(+33.6%) | $15.99B(+4.3%) |
Sep 2010 | - | $3.80B(+7.9%) | $15.32B(+2.8%) |
Jun 2010 | - | $3.52B(-1.7%) | $14.90B(-0.1%) |
Mar 2010 | - | $3.58B(-18.8%) | $14.91B(+2.5%) |
Dec 2009 | $14.28B(+1.4%) | $4.41B(+30.6%) | $14.55B(+5.3%) |
Sep 2009 | - | $3.38B(-4.4%) | $13.82B(-0.7%) |
Jun 2009 | - | $3.53B(+9.6%) | $13.92B(-1.0%) |
Mar 2009 | - | $3.23B(-12.4%) | $14.06B(-0.1%) |
Dec 2008 | $14.08B(+6.2%) | $3.68B(+6.1%) | $14.07B(+0.0%) |
Sep 2008 | - | $3.47B(-5.5%) | $14.06B(+2.1%) |
Jun 2008 | - | $3.68B(+13.5%) | $13.77B(+2.7%) |
Mar 2008 | - | $3.24B(-12.0%) | $13.42B(+0.6%) |
Dec 2007 | $13.26B(+10.7%) | $3.68B(+15.7%) | $13.34B(+1.4%) |
Sep 2007 | - | $3.18B(-4.1%) | $13.16B(-5.1%) |
Jun 2007 | - | $3.32B(+4.9%) | $13.86B(+2.9%) |
Mar 2007 | - | $3.16B(-9.5%) | $13.47B(+3.6%) |
Dec 2006 | $11.97B(+8.1%) | $3.50B(-10.0%) | $13.01B(+36.8%) |
Sep 2006 | - | $3.88B(+32.6%) | $9.51B(+69.0%) |
Jun 2006 | - | $2.93B(+8.5%) | $5.63B(+108.5%) |
Mar 2006 | - | $2.70B(>+9900.0%) | $2.70B(>+9900.0%) |
Dec 2005 | $11.08B(+7.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2004 | $10.35B(+11.9%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2003 | $9.26B(+14.6%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2002 | $8.08B(+7.5%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2001 | $7.51B(-2.5%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) | $0.00(-100.0%) |
Mar 2001 | - | $0.00(0.0%) | $1.65B(0.0%) |
Dec 2000 | $7.71B(+4.9%) | $0.00(-100.0%) | $1.65B(0.0%) |
Jun 2000 | - | $1.65B | $1.65B |
Dec 1999 | $7.35B(+0.8%) | - | - |
Dec 1998 | $7.29B(-2.6%) | - | - |
Dec 1997 | $7.48B(-21.9%) | - | - |
Dec 1996 | $9.58B(-1.4%) | - | - |
Dec 1995 | $9.72B(+4.7%) | - | - |
Dec 1994 | $9.29B(+2.9%) | - | - |
Dec 1993 | $9.02B | - | - |
FAQ
- What is Novartis AG annual SGA?
- What is the all time high annual SGA for Novartis AG?
- What is Novartis AG annual SGA year-on-year change?
- What is Novartis AG quarterly SGA?
- What is the all time high quarterly SGA for Novartis AG?
- What is Novartis AG quarterly SGA year-on-year change?
- What is Novartis AG TTM SGA?
- What is the all time high TTM SGA for Novartis AG?
- What is Novartis AG TTM SGA year-on-year change?
What is Novartis AG annual SGA?
The current annual SGA of NVS is $0.00
What is the all time high annual SGA for Novartis AG?
Novartis AG all-time high annual SGA is $17.86B
What is Novartis AG annual SGA year-on-year change?
Over the past year, NVS annual SGA has changed by -$12.52B (-100.00%)
What is Novartis AG quarterly SGA?
The current quarterly SGA of NVS is $3.50B
What is the all time high quarterly SGA for Novartis AG?
Novartis AG all-time high quarterly SGA is $5.08B
What is Novartis AG quarterly SGA year-on-year change?
Over the past year, NVS quarterly SGA has changed by +$406.27M (+13.14%)
What is Novartis AG TTM SGA?
The current TTM SGA of NVS is $174.22B
What is the all time high TTM SGA for Novartis AG?
Novartis AG all-time high TTM SGA is $217.64B
What is Novartis AG TTM SGA year-on-year change?
Over the past year, NVS TTM SGA has changed by +$161.75B (+1297.55%)